AI assistant
MESOBLAST LTD — Capital/Financing Update 2015
Oct 29, 2015
31658_rns_2015-10-29_2a4c8f12-68ef-4873-a2b6-e695b01b1e37.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer

MARKET RELEASE
30 October 2015
Mesoblast Limited
SUSPENSION FROM OFFICIAL QUOTATION
The securities of Mesoblast Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement by the Company.
Security Code: MSB
Cheng Tang
ADVISER, LISTINGS COMPLIANCE (MELBOURNE)
Level 4, North Tower, Rialto 525 Collins Street Melbourne VIC 3000
www.asx.com.au Customer service 13 12 79 03 9617 8706 [email protected]

Mesoblast Limited ABN 68 109 431 870
Corporate Headquarters Level 38
55 Collins Street Melbourne, Victoria 3000 ALISTRALIA
$T + 61396396036$ $F + 61$ 3 9639 6030
United States Operations 505 Fifth Avenue Third Floor New York, NY 10017 LISA
$T + 12128802060$ $F + 12128802061$
Asia 20 Biopolis Way #05-01 Centros Biopreneur 3 SINGAPORE 138668
$t + 6565700635$ $F + 6565700176$
[email protected] www.mesoblast.com
Dear Sir
30 October 2015
Mr James Gerraty Advisor ASX Markets Supervision Pty Ltd Level 4 Rialto Towers 525 Collins Street MELBOURNE VIC 3000
Request for suspension at the request of Mesoblast Limited (ASX:MSB)
The directors of Mesoblast Limited ACN 109 431 870 (ASX: MSB) (Mesoblast) request that ASX suspend the Company's securities from quotation from the commencement of trading on 30 October 2015.
The suspension is requested in connection with a potential international capital raising, the details in respect of which are ongoing.
For the purposes of Listing Rule 17.2, Mesoblast provides the following information:
the suspension is necessary as Mesoblast expects to make an announcement in $(a)$ connection with the potential capital raising:
- $(b)$ Mesoblast expects that the suspension to remain in place until no later than the close of trading on 13 November 2015;
- $(c)$ Mesoblast expects that an announcement with respect to the conclusion and results of the capital raising will end the suspension; and
- $(d)$ Mesoblast is not aware of any reason why the securities should not be suspended.
Yours sincerely
$Ml$ Peter T Howard General Counsel Mesoblast Limited
This letter shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.